A new study conducted at the Breast Health Center at Loma Linda University Health, California, indicates that mastectomy may increase odds of survival in women with stage 4 HER2-positive breast cancer when compared to other treatment regimens, such as chemotherapy or hormonal therapy. The study involved 3,200 U.S. women with stage 4 HER2-positive breast cancer who underwent 4 different kinds of therapy: chemotherapy (90%) hormonal therapy (38%), surgery (35%), and radiation (32%). Of the 38% of women who underwent surgery (mastectomy), there was a "44% increased change of survival, assuming that most patients were also treated with systemic therapies."
To read more about this study, click here.
